Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 1151-1176 of 1176 result(s).
CYDY CytoDyn Inc
04/03/2024 2:07:09 AM
https://www.pharmaceutical-technol (3)
CYDY CytoDyn Inc
04/02/2024 11:17:35 PM
Yea, if Dr. Patterson tries that, h (2)
CYDY CytoDyn Inc
04/02/2024 11:15:21 PM
"Our best option at the moment, as (2)
CYDY CytoDyn Inc
04/02/2024 10:14:50 PM
1/13/2021 cancers patent covers " a (5)
CYDY CytoDyn Inc
04/02/2024 9:31:56 PM
July 25th, 2023: "MAGICAL identifie (5)
CYDY CytoDyn Inc
04/02/2024 8:28:00 PM
Cytodyn Director Lishomwa C. Ndhlov (8)
CYDY CytoDyn Inc
04/01/2024 10:17:55 AM
Shout out to MGK_2. Yesterday made (2)
CYDY CytoDyn Inc
04/01/2024 9:26:53 AM
Sure. I think the jist of it was, o (4)
CYDY CytoDyn Inc
04/01/2024 1:07:46 AM
MGK_2, OHM, Respert, Sean & so many (15)
CYDY CytoDyn Inc
03/31/2024 10:13:40 AM
MGK_2, looks to me they have taken (6)
CYDY CytoDyn Inc
03/31/2024 2:29:36 AM
So, even after patents expire, up u (5)
CYDY CytoDyn Inc
03/31/2024 1:16:13 AM
Feb. 2023 Cytodyn patent: " The pre (9)
CYDY CytoDyn Inc
03/26/2024 10:04:46 PM
Wow. Thx. (1)
CYDY CytoDyn Inc
03/24/2024 9:41:27 AM
The Dec. 15th, 2022 grand jury indi (6)
CYDY CytoDyn Inc
03/21/2024 9:40:15 AM
Nov. 2023 Investor Letter: Further, (5)
CYDY CytoDyn Inc
03/21/2024 6:31:00 AM
Thanks for taking the time to add-o (1)
CYDY CytoDyn Inc
03/20/2024 6:12:35 PM
A GBM study 8 days ago: " The resea (8)
CYDY CytoDyn Inc
03/17/2024 11:15:35 AM
A re-touch on Dr. J's past mindset (4)
CYDY CytoDyn Inc
03/17/2024 11:03:44 AM
That's the beauty of where finally (2)
CYDY CytoDyn Inc
03/16/2024 5:50:28 PM
Agreed, 100%. 2024 will be start of (2)
CYDY CytoDyn Inc
03/16/2024 5:23:07 PM
Bingo. Was just 1 of the much shuff (5)
CYDY CytoDyn Inc
03/16/2024 5:19:31 PM
Dr. J wanted it in the press releas (4)
CYDY CytoDyn Inc
03/16/2024 11:27:28 AM
May 2020, months before DSC severe/ (4)
CYDY CytoDyn Inc
03/16/2024 10:59:44 AM
What really confused me on the Data (16)
CYDY CytoDyn Inc
03/15/2024 5:26:00 PM
Dr. J's 2 Vs 4 dosage: pointed it o (14)
CYDY CytoDyn Inc
03/15/2024 4:42:23 PM
1st post here. Yrs of posting, etc. (7)
Go to page:
  • << First
  • < Previous
  • 23
  • 24
  • Next >

Recent Articles

  • Ervexia Occupational Health Expands with Franchising Opportunities
  • Explore the Advantages of Rackspace Technology's Cloud Solutions
  • Financial Executives International Welcomes New Board Members
  • Ascent Solar Technologies Embraces Growth and Innovation Journey
  • Enphase Energy Set to Discuss Q2 2025 Financial Performance
  • Sonoco Partners with Pet Sustainability Coalition to Foster Eco-Friendly Packaging
  • UFP Technologies, Inc. Engages Investors at Key Conference Event
  • Esperion's Settlement Agreement Secures Future for NEXLETOL®
  • TTM Technologies Unveils Innovative Radiation-Hardened Regulator
  • Treatment.com AI Propels Forward After Rocket Doctor Acquisition
  • Alignment Healthcare Achieves Major Legal Success in Arizona
  • Recursion Acquires REV102 to Revolutionize HPP Treatment
  • LakeShore Biopharma Secures $15 Million in Private Funding
  • Innova Partners with Atrato for Strategic Solar Project
  • Amaero Drives Innovation Through Partnership with Auburn University
  • Stallion Uranium Leverages Cutting-Edge Technology for Exploration
  • Baiya International Group's Growth Trajectory Post-IPO Insights
  • Innovative Partnership Boosts Slacker Radio Subscription Growth
  • Crescent Biopharma Welcomes Jan Pinkas, Ph.D. as New CSO
  • Intermex Introduces Innovative RaaS Platform for Businesses
  • Dynacor Expands Gold Processing Operations with New Acquisition
  • DoubleDown Interactive's Strategic Acquisition of WHOW Games
  • Lumber Liquidators Relocates Huntsville Store for Community Growth
  • Alibaba's Strategic Shift in Instant Delivery Expands Market Reach
  • Akebia Therapeutics Highlighting Innovations at Upcoming Conference
  • Michael J. Petro Takes the Helm as CFO of Martin Marietta
  • Sysco Corporation to Reveal Financial Insights on July 29
  • Jeffs' Brands Closes Fort Product Acquisition and Growth Plans
  • Insights on Nokia Corporation's Recent Shares Transfer and Impact
  • Sohail Khan Joins POET Technologies Board as New Director
  • Current Insights on Octopus AIM VCT plc: NAV Update
  • ReserveOne Aims to Transform Digital Asset Management Landscape
  • Dynacor Expands Operations with Ecuador Processing Plant Acquisition
  • Octopus Investments' Recent Disclosure on Marlowe plc Holdings
  • ZyVersa Advances VAR 200 in Compassionate Use for Rare Disease
  • Cryoport Innovates with New Shipping Solutions for Biologics
  • Analysts Update Ratings for Southwest Gas and Others
  • Soligenix Updates on Pipeline Progress and Future Directions
  • Auxly's Strategic Debt Reduction: A Path to Financial Strength
  • BTQ Technologies Unveils a Revolutionary Quantum Simulator
  • Outcrop Silver Validates High-Grade Silver Growth Potential
  • Curaleaf Increases European Market Control Through Acquisition
  • Cochlear Innovates with Next-Gen Cochlear Implant System
  • BizClik's July Editions Unveil Insights Across Key Industries
  • Curaleaf Holdings Enhances Control with 100% Acquisition of Curaleaf International
  • Octopus AIM VCT 2 plc Reports Significant Asset Value Surprise
  • Innovative Partnership Propels Stallion Uranium Forward
  • Plus Therapeutics Begins Treatment in Innovative Cancer Trial
  • Bread Financial Plans Earnings Call for Q2 Results Discussion
  • MariMed Readies for Second Quarter 2025 Earnings Announcement
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site